C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 277/82 (2006.01) A61K 31/425 (2006.01) A61K 31/5377 (2006.01) A61K 31/55 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2607426
A series of 5,6-dihydro-l,3-benzothiazol-7(4H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PD kinase enzymes, are accordingly of b.enefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
L'invention concerne une série de dérivés de la 5,6-dihydro-l,3-benzothiazol-7(4H)-one, et leurs analogues, substitués en position 2 par un groupe morpholin-4-yle éventuellement substitué, agissant comme des inhibiteurs sélectifs des enzymes PD kinases, et utiles en médecine, par exemple pour le traitement de maladies inflammatoires, auto-immunes, cardiovasculaires, neurodégénératrices, métaboliques, oncologiques, nociceptives ou ophtalmiques.
Alexander Rikki Peter
Aujla Pavandeep
Batchelor Mark James
Brookings Daniel Christopher
Buckley George Martin
Robic
Ucb Pharma S.a.
LandOfFree
Fused thiazole derivatives as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused thiazole derivatives as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused thiazole derivatives as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1851985